NEPHROPLUS2026-08-12NEPHROPLUS2026-08-122026-08-12NEPHROPLUS2026-08-12in-capmkt:FinancialYear1MemberNEPHROPLUS2026-08-12in-capmkt:FinancialYear2MemberNEPHROPLUS2026-08-12in-capmkt:FinancialYear3MemberNEPHROPLUS2026-08-122026-08-12in-capmkt:FinancialYear1MemberNEPHROPLUS2026-08-122026-08-12in-capmkt:FinancialYear2MemberNEPHROPLUS2026-08-122026-08-12in-capmkt:FinancialYear3Memberiso4217:INRxbrli:pure544647Nephrocare Health Services LimitedNEPHROPLUSNAINE428V01029NewAcquisition (including agreement to acquire)true2026-08-1117:10:002026-08-12NephroPlus Kidney Services Company ("NPKSC")Step Down SubsidiaryNephrocare Health Services Saudi Arabia Company (“NHSSAC”)00111500000true2026-08-112026-08-11falsefalsetrueHealthcare services - dialysis services.The proposed transaction is being undertaken as part of an internal restructuring of the Group’s overseas holding structure, with a view to streamlining and optimising the ownership structure of the Group’s operations in the Kingdom of Saudi Arabia and strengthening governance, operational oversight and strategic alignment. The business of NHSSAC is in line with the principal business activities of the Company and the Group. As NPKSC is a wholly owned subsidiary of NHSI, which in turn is a wholly owned subsidiary of the Company, the proposed transaction will not result in any change in the ultimate beneficial ownership or control of NHSSAC.YesThe proposed transaction is subject to receipt of the requisite governmental and/or regulatory approvals and compliance with the applicable laws and regulations in the relevant jurisdictions, including Singapore and the Kingdom of Saudi Arabia, as may be applicable.falseThe proposed transaction is expected to be completed upon receipt of the requisite approvals and completion of the applicable legal, regulatory and other formalities.Cash56900000The total consideration for the proposed transfer of the 51% shareholding in NHSSAC shall be Saudi Riyal (“SAR”) 2.24 million (approximately ₹5.69 crore, based on an exchange rate of ₹25.3979 per SAR as on 11th August 2026).5690000000.51NHSSAC is incorporated in the Kingdom of Saudi Arabia and is engaged in the business of providing dialysis services. Country of presence: Kingdom of Saudi Arabia. NHSI presently holds 51% of the shareholding in NHSSAC, with the remaining 49% held by the local joint venture partner. Pursuant to the proposed internal restructuring, NHSI’s entire 51% shareholding is proposed to be transferred to NPKSC.2023-01-042025-202602024-202502023-20240Kingdom of Saudi Arabia